Alaa Khushhal

Dr. Alaa Khushhal


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AKAlaa Khushhal
Alaa Khushhal
SNSimon J. Nichols
Simon J. Nichols
SCSean Carroll
Sean Carroll
GAGrant Abt
Grant Abt
LILee Ingle
Lee Ingle
In recent years, criticism of the percentage range approach for individualised exercise prescription has intensified and we were concerned that sub-optimal exercise dose (especially intensity) may be in part responsible for the variability in the effectiveness of cardiac rehabilitation (CR) programmes in the United Kingdom (UK). The aim was to investigate the fidelity of a structured Phase III CR programme, by monitoring and quantifying exercise training intensity. Observational study. The programme comprised 16 sessions over 8 weeks, where patients undertook an interval, circuit training approach within national guidelines for exercise prescription (40–70% heart rate reserve [HRR]). All patients wore an Apple Watch (Series 0 or 2, Watch OS2.0.1, Apple Inc., California, USA). We compared the mean % heart rate reserve (%HRR) achieved during the cardiovascular training component (%HRR-CV) of a circuit-based programme, with the %HRR during the active recovery phases (%HRR-AR) in a randomly selected cohort of patients attending standard CR. We then compared the mean %HRR-CV achieved with the minimal exercise intensity threshold during supervised exercise (40% HRR) recommended by national governing bodies. Thirty cardiac patients (83% male; mean age [SD] 67 [10] years; BMI 28.3 [4.6] kg∙m-2) were recruited. We captured 332 individual training sessions. The mean %HRR-CV and %HRR-AR were 37 (10) %, and 31 (13) %, respectively. There was weak evidence to support the alternative hypothesis of a difference between the %HRR-CV and 40% HRR. There was very strong evidence to accept the alternative hypothesis that the mean %HRR-AR was lower than the mean %HRR-CV, median standardised effect size 1.1 (95%CI: 0.563 to 1.669), with a moderate to large effect. Mean exercise training intensity was below the lower limit of the minimal training intensity guidelines for a Phase III CR programme. These findings may be in part responsible for previous reports highlighting the significant variability in effectiveness of UK CR services and poor CRF improvements observed from several prior investigations.

1 March 2024 in Journal of Multidisciplinary Healthcare
Verified
Journal Article
Open access
PDF file
AKAlaa Khushhal
Alaa Khushhal
AMAshraf Abdelaal Mohamed
Ashraf Abdelaal Mohamed
MEMahmoud Elshahat Elsayed
Mahmoud Elshahat Elsayed
Background: The validity of the Apple Watch to measure the heart rate (HR) and oxygen saturation (Spo2) for patients with chronic diseases such as diabetes mellitus (DM), dyslipidemia, and hypertension is still unclear. Therefore, this study aims to investigate the accuracy of the Apple Watch in measuring the Spo2 and HR in patients with chronic diseases. Methods: Forty-one patients with chronic diseases, including 20 with hypertension, 10 with diabetes, and 11 with dyslipidemia, completed a cross-sectional study. All participants used the Apple Watch against the Polar chest strap and the pulse oximeter at rest and during moderate intensity exercise sessions to measure HR and the SpO2 at rest for 5 minutes, during exercise for 16 minutes, and followed by 3 minutes of rest. The HR was measured during all previous periods, but evaluation of the Spo2 included 5 measures, done only before and after exercise, with a minute interval between each measure. Results: Overall, a strong correlation exists between measuring the SpO2 using the Apple Watch against the pulse oximeter (Contec) at rest (r = 0.92, p < 0.001) and after exercise (r = 0.86, p < 0.001) in all patients. The HR had a very strong correlation between the Apple Watch and the Polar chest strap (r = 0.99, p < 0.001) in all patients. There was no significant difference (p = 0.76) between the twenty-seven white and fourteen brown-skinned patients. Conclusion: The Apple Watch is valid to measure the HR and SpO2 in patients with chronic diseases. Clinical Trial Registration No: NCT05271864.

1 March 2023 in Journal of Multidisciplinary Healthcare
Verified
Journal Article
Open access
PDF file
AKAlaa Khushhal
Alaa Khushhal
MAMohammed Alsubaiei
Mohammed Alsubaiei
Background: The core of cardiac rehabilitation (CR) is structured exercise training. CR reduces 28– 56% hospital readmission rate, and around 25% increases cardiorespiratory fitness but the number of outpatients CR centers in Saudi Arabia (SA) is very limited and there is a need to establish outpatient CR (Phase III) in SA. Furthermore, the awareness of outpatient CR in SA is unknown. Aim: To determine the main barriers to establishing an outpatient CR program (Phase III) in the western region of SA, as well as assess the awareness of outpatient CR (Phase III) in the western region of SA. Methods: A cross-sectional study survey was conducted between March – July 2021 among physiotherapists, cardiologists and the cardiac surgeon using a questionnaire distributed electronically to determine the awareness level of outpatient CR and barriers to establishing outpatient CR (Phase III) in the western region of SA. Frequencies and percentages were used to report the variables. Results: Of the 141 participants who completed the online survey, our findings showed that 131 (93%) were aware of CR but only 29 (21%) were aware of the four phases of CR. There were three main barriers to establishing CR: lack of appropriate CR 135 (96%); lack of awareness among healthcare professions of CR and its benefits 134 (95%) and the lack of healthcare providers trained in CR 133 (94%). There was a significant relationship between physiotherapists and cardiologists’ responses on agreeing to all barriers to establishing CR in SA (r=0.69, P =0.03). Conclusion: To overcome the barriers to establishing CR outpatient centers in the western region of SA, it is recommended to provide more CR outpatient training programs to healthcare providers and raise the awareness of the CR phases, its benefits, and the risk factors for developing cardiac diseases among healthcare providers.

1 January 2025 in Journal of Multidisciplinary Healthcare
Verified
Journal Article
Open access
PDF file
AKAlaa Khushhal
Alaa Khushhal
AMAshraf Abdelaal Mohamed
Ashraf Abdelaal Mohamed
MAMohammad Matook Alsegame
Mohammad Matook Alsegame
AAAtif Mohammed Alsaedi
Atif Mohammed Alsaedi
Background: Electrocardiography (ECG) is a standard method for studying the heart rate and heart electricity. The Apple Watch has recently been used to measure heart electricity via 30 seconds of ECG monitoring, but its validity is not known. Methods: A cross-sectional study included a sample of 112 patients with chronic disorders, including cardiac patients with sinus rhythm, cardiac patients with irregular heart rhythm, and patients with diabetes, hypertension, and dyslipidemia; their cardiac activity was investigated using the Apple Watch and ECG. Results: The correlations were strong between the Apple Watch and the 12-lead ECG in the heart rate, PR intervals, QT intervals, QRS complex, and RR intervals in all patients’ subcategories (cardiac, hypertension, diabetic, and dyslipidemia patients). Conclusion: The Apple Watch is valid for carrying out ECG in measuring the heart rate, PR intervals, QT intervals, QRS complex, and RR intervals of patients with cardiac and chronic diseases at rest; this may help in initial diagnosis for patients with cardiac diseases or those who are at risk of developing cardiac disease in the future.

2 September 2025 in Global Heart
Verified
Journal Article
Open access
PDF file
AKAlaa Khushhal
Alaa Khushhal
AMAshraf Abdelaal Mohamed
Ashraf Abdelaal Mohamed
MEMahmoud Elshahat Elsayed
Mahmoud Elshahat Elsayed
The validity of Apple Watch for measuring heart rate (HR) and oxygen saturation (SpO2) in patients with cardiac diseases is still unclear. Therefore, this study aimed to investigate the accuracy of the Apple Watch in measuring HR and SpO2 in patients with cardiac diseases. A cross-sectional study recruited 260 cardiac patients, including 190 with regular heart rhythm and 70 with cardiac arrhythmia. Each patient wore the Apple Watch alongside a Polar HR monitor at rest, during and after mild- to moderate-intensity exercise sessions, and wore the Apple Watch alongside a Contec pulse oximeter at rest and after exercise. The Apple Watch showed excellent validity (ICC = 0.100) in measuring the HR at rest, during mild- to moderate-intensity exercise, and after exercise in cardiac patients, as well as in measuring SpO2 at rest (ICC = 0.100) and after exercise (ICC = 0.92). However, the validity of the Apple Watch for measuring SpO2 decreased slightly after exercise (ICC = 0.85; good validity), especially in patients with an irregular heart rhythm. Overall, the Apple Watch appears valid for measuring HR and SpO2 at rest and after exercise, and for measuring HR during mild- to moderate-intensity training in cardiac patients.

1 November 2025 in The Journal of Sports Medicine and Physical Fitness
Verified
Journal Article
Closed access
AKAlaa Khushhal
Alaa Khushhal
The Apple Watch measures heart rate, but its validity decreases with high exercise intensities, so this study investigated whether pairing the Apple Watch with a polar chest strap could be more accurate than the Apple Watch alone in measuring heart rate during high intensity exercises and in recovery from exercises. A cross-sectional study measured heart rate on the Apple Watch compared to the Apple Watch paired with the Polar chest strap on 30 healthy subjects. Each participant has done three minutes of low, moderate, and high exercise intensities using both the treadmill and cycle for 9 minutes each, followed by 3 minutes of recovery after each treadmill and cycle. There were excellent correlations between the Apple Watch and Polar chest strap during low (r=0.99 Treadmill, r=0.99 cycle), moderate (r=0.99 treadmill, r=0.99 cycle), and high (r=0.96 treadmill, r=0.99 cycle), exercise intensities and in recovery from Treadmill and Cycle (r=0.97 treadmill, r=0.98 cycle). There were excellent correlations between the combined Apple Watch with Polar chest strap and the Apple Watch alone during low (r=1.00 treadmill, r=0.99 cycle), moderate (r=0.99 treadmill, r=0.99 cycle), and high (r=0.99 treadmill, r=0.99 cycle) exercise intensities and in recovery from Treadmill and Cycle (r=1.00 treadmill, r=0.99 cycle). The Apple Watch is valid for measuring heart rate during low to moderate exercise intensity, and its validity can be increased at high exercise intensities or after recovery from exercise by adding it to the Polar chest strap and holding hands on the handrail while performing exercises.